Embecta Shares Gain As Q1 Earnings Exceed Expectations

Loading...
Loading...
  • Embecta Corp EMBC posted Q1 FY23 revenues of $275.7 million, down 4.7% on a reported basis and up 0.7% on a constant currency basis, beating the consensus of $262.90 million.
  • Lower revenues were driven by unfavorable effects from foreign currency translation primarily due to the strengthening of the U.S. dollar.
  • The company posted an adjusted EPS of $0.96, beating the consensus of $0.51.
  • U.S. revenues decreased by 1.1% on both a reported and constant currency basis.
  • International revenues decreased 8.7% on a reported basis and increased 2.6% on a constant currency basis.
  • The company posted adjusted gross profit and margin of $188.9 million and 68.5%, respectively.
  • Operating income and margin of $88.8 million and 32.2%, compared to $116.6 million and 40.3% in the prior year period.
  • Outlook: Embecta has raised its FY23 guidance with revenues of $1.084-$1.107 billion, up from $1.05-$1.073 billion vs. an estimate of $1.06 billion.
  • It forecasts adjusted EPS of $2.20-$2.35 versus the prior guidance of $1.75 - $2.00 and the consensus of $1.90.
  • Price Action: EMBC shares are up 9.13% at $31.02 on the last check Tuesday.
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsLarge CapNewsGuidanceHealth CareSmall CapGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...